Global Pharma and Cetirizine OTC Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Pharma and Cetirizine OTC Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria.[1] It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.
Pharma and Cetirizine OTC report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pharma and Cetirizine OTC market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
In United States, Pharma and Cetirizine OTC key players include J & J, SANOFI-AVENTIS US LLC, PL DEVELOPMENTS INC, APOTEX, Teva, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharma and Cetirizine OTC market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
J & J
SANOFI-AVENTIS US LLC
PL DEVELOPMENTS INC
APOTEX
Teva
MCKESSON CORP
Perrigo
Taro Pharmaceutical
CVS Pharmacy
Major® Pharmaceuticals
Mylan
Amneal
NOVARTIS
Cardinal
Jubilant Life Sciences
Novel Laboratories
Medline
Macleods
Torrent Pharmaceuticals
Micro Labs Limited
Dr. Reddy's Laboratories
Cipla
Aurobindo Pharma
Glenmark
Synthon
Magno-Humphries
Unique Pharmaceutical
ALLEGIANT HEALTH
Silarx Pharmaceuticals
Sun Pharma
UNICHEM LABORATORIES LTD
Pro Doc Limitee
NorthStar Rx LLC
ACETO
Strides Shasun
Segment by Type
Tablet
Capsule
Hospital
Clinic
Drug Store
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Pharma and Cetirizine OTC market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pharma and Cetirizine OTC, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pharma and Cetirizine OTC industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pharma and Cetirizine OTC in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pharma and Cetirizine OTC introduction, etc. Pharma and Cetirizine OTC Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pharma and Cetirizine OTC market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Pharma and Cetirizine OTC report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pharma and Cetirizine OTC market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
In United States, Pharma and Cetirizine OTC key players include J & J, SANOFI-AVENTIS US LLC, PL DEVELOPMENTS INC, APOTEX, Teva, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharma and Cetirizine OTC market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
J & J
SANOFI-AVENTIS US LLC
PL DEVELOPMENTS INC
APOTEX
Teva
MCKESSON CORP
Perrigo
Taro Pharmaceutical
CVS Pharmacy
Major® Pharmaceuticals
Mylan
Amneal
NOVARTIS
Cardinal
Jubilant Life Sciences
Novel Laboratories
Medline
Macleods
Torrent Pharmaceuticals
Micro Labs Limited
Dr. Reddy's Laboratories
Cipla
Aurobindo Pharma
Glenmark
Synthon
Magno-Humphries
Unique Pharmaceutical
ALLEGIANT HEALTH
Silarx Pharmaceuticals
Sun Pharma
UNICHEM LABORATORIES LTD
Pro Doc Limitee
NorthStar Rx LLC
ACETO
Strides Shasun
Segment by Type
Tablet
Capsule
Segment by Application
Hospital
Clinic
Drug Store
Other
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Pharma and Cetirizine OTC market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pharma and Cetirizine OTC, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pharma and Cetirizine OTC industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pharma and Cetirizine OTC in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pharma and Cetirizine OTC introduction, etc. Pharma and Cetirizine OTC Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pharma and Cetirizine OTC market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.